Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report

  title={Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report},
  author={Peter Malfertheiner and Francis M{\'e}graud and C O'Morain and Franco Bazzoli and Emad M El-Omar and David Yates Graham and R H Hunt and Theodoros Rokkas and Nimish Vakil and Ernst J. Kuipers},
  pages={772 - 781}
Background: Guidelines on the management of Helicobacter pylori, which cover indications for management and treatment strategies, were produced in 2000. Aims: To update the guidelines at the European Helicobacter Study Group (EHSG) Third Maastricht Consensus Conference, with emphasis on the potential of H pylori eradication for the prevention of gastric cancer. Results: Eradication of H pylori infection is recommended in (a) patients with gastroduodenal diseases such as peptic ulcer disease and… 

Tables from this paper

Management of Helicobacter pylori infection after gastric surgery.
This review focuses on the microenvironment change in the stomach after gastrectomy, the phenomenon of spontaneous clearance of H. pylori after gast rectomy, and optimal timing, eradication regimens, diagnostic tools, and follow-up strategies for patients undergoing Gastrectomy.
Revised french recommendations on the management of Helicobacter pylori infection
The gastric and duodenal ulcers are indications of research and eradication of H. pylori that should be sought and treated in patients with a family history of gastric cancer in the first degree and mutations in DNA mismatch repair genes (HNPCC), pre-neoplastic lesions.
American College of Gastroenterology Guideline on the Management of Helicobacter pylori Infection
Whether to test for H. pylori in patients with functional dyspepsia, gastroesophageal reflux disease (GERD), patients taking nonsteroidal antiinflammatory drugs, with iron deficiency anemia, or who are at greater risk of developing gastric cancer remains controversial.
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
In this 4th edition of the Maastricht consensus report aspects related to the clinical role of H pylori were looked at again in 2010, with recommendations to guide doctors involved in the management of this infection associated with various clinical conditions.
Helicobacter pylori management in ASEAN: The Bangkok consensus report
Helicobacter pylori (H. pylori) infection remains to be the major cause of important upper gastrointestinal diseases such as chronic gastritis, peptic ulcer, gastric adenocarcinoma, and
"Cervia II Working Group Report 2006": guidelines on diagnosis and treatment of Helicobacter pylori infection in Italy.
  • M. Caselli, A. Zullo, G. Gasbarrini
  • Medicine, Biology
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
  • 2007
Helicobacter pylori infection and current clinical areas of contention
The main clinical challenge remains prevention of H. pylori-related diseases by effective treatment and screening procedures and strategies for gastric cancer prevention include serological screening, which allow adopting eradication therapy in individuals at high risk.
Advances in the treatment of Helicobacter pylori infection in children
This review elaborate on two main questions concerning the management of Helicobacter pylori infection in children and recommends that treatment tailored to susceptibility testing should be the first choice in pediatric patients.
Helicobacter pylori Infection - Management from a European Perspective
Since the first European Consensus Report on Helicobacter pylori management in 1996 and the strong indication for therapy of peptic ulcer disease and other benign gastroduodenal pathologies, the list
Therapie der Helicobacter-pylori- Infektion
Peptic ulcer, early gastric cancer, familial risk for Gastric cancer and associated atrophic gastritis are strong treatment indications for Helicobacter (H.) pylori eradication, however following complications due to NSAID's and aspirin, additional long term proton pump inhibitor (PPI) therapy is mandatory.


Strategy for treatment of Helicobacter pylori infection in adults. I. Updated indications for test and eradication therapy suggested in 2000.
Intervention studies are now in progress to test the hypothesis that prevention of gastric malignancy is an outcome of H. pylori eradication, and the acceptable indications of eradication therapy will vary among countries.
Current European concepts in the management of Helicobacter pylori infection--the Maastricht Consensus Report. The European Helicobacter Pylori Study Group (EHPSG).
There was consensus that treatment regimens should be simple, well tolerated and achieve an eradication rate of over 80% on an intention to treat basis.
Helicobacter pylori infection and gastro-oesophageal reflux disease: coincidence or association?
Eradication of H. pylori infection appears advisable in patients on long-term proton pump inhibitors and an increase of inflammatory activity in fundic and corpus mucosa is a consistent phenomenon, in the authors' opinion.
Symptomatic benefit 1–3 years after H. pylori eradication in ulcer patients: impact of gastroesophageal reflux disease
A substantial proportion of ulcer patients have symptoms and/or signs of coexisting gastroesophageal reflux disease (GERD) at initial presentation and this reduces the symptomatic benefit from H. pylori eradication, and there is no evidence that eradicating H.pylori induces de novo GERD symptoms in ulcers patients.
Canadian Helicobacter Study Group Consensus Conference on the Approach to Helicobacter pylori Infection in Children and Adolescents.
Diagnostic tests should be employed judiciously and be reserved for children who are most likely to derive measurable benefit, such as those likely to have peptic ulcer disease.
Canadian Helicobacter Study Group Consensus Conference: Update on the approach to Helicobacter pylori infection in children and adolescents--an evidence-based evaluation.
An evidence-based appraisal of 14 topics was undertaken in a consensus conference to update guidelines based on the best available evidence using an established and uniform methodology to address and formulate recommendations for each topic.
Management of Peptic Ulcers: Emerging Issues
  • J. Freston
  • Medicine, Biology
    World Journal of Surgery
  • 2000
Evidence suggests that H. pylori eradication may foster the development of erosive esophagitis, but confirmatory studies are needed and studies also suggest an interaction between H. Pylori infection and peptic ulcers related to the use of nonsteroidal antiinflammatory drugs (NSAIDs).
Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial
Most H pylori positive GORD patients have a corpus predominant pangastritis during omeprazole maintenance therapy and should be eradicated, according to the Sydney classification system.
Is Eradication Therapy Useful as the First Line of Treatment in Helicobacter pylori-Positive Idiopathic Thrombocytopenic Purpura? Analysis of 207 Eradicated Chronic ITP Cases in Japan
H pylori infection was involved in most ITP patients older than 40 years in Japan, and eradication therapy should be the first line of treatment in H pylonori-positive ITP Patients.